2. Peptides
  3. Peptide and Derivatives
  4. Others
  5. Dipeptides

Dipeptides (248):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-113110
    Cysteinylglycine 19246-18-5 99.96%
    Cysteinylglycine is a dipeptide produced by the decomposition of extracellular glutathione catalyzed by γ-glutamyl transpeptidase. Cysteinylglycine is a highly reactive metabolite. Cysteinylglycine is currently mainly used in neurodegenerative diseases and breast cancer research.
    Cysteinylglycine
  • HY-P4632
    H-γ-Glu-Leu-OH 2566-39-4 99.67%
    H-γ-Glu-Leu-OH (γ-Glu-Leu) is a dipeptide consisting of γ-glutamic acid and leucine, terminated by a hydroxyl group.
    H-γ-Glu-Leu-OH
  • HY-D0889
    Glycylglycine 556-50-3 99.90%
    Glycylglycine is a non-selective glycylglycine dipeptidase substrate and iNOS inhibitor. Glycylglycine can cross the cell membrane by passive diffusion and is hydrolyzed to glycine in the cell, participating in energy metabolism and antioxidant processes. Glycylglycine promotes spermatogonial stem cells (SSCs) proliferation, inhibits astrocyte overactivation and reduces nitric oxide (NO) release, while upregulating the expression of neurotrophic factors (such as PDGFA, FGF2, CNTF) to support nerve myelin repair. Glycylglycine can be used to study male reproductive biology (such as SSCs proliferation regulation) and neurodegenerative diseases (such as neuroprotective mechanisms in multiple sclerosis).
    Glycylglycine
  • HY-101399
    γ-Glu-Phe 7432-24-8 99.44%
    γ-Glu-Phe (γ-Glutamylphenylalanine) is synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe or the post-enzymatic reaction mixture enhances the umami intensity of commercial soy sauce and model chicken broth.
    γ-Glu-Phe
  • HY-W015450
    D-Ala-D-Ala 923-16-0 ≥98.0%
    D-Ala-D-Ala is a bacterial endogenous metabolite. D-Ala-D-Ala constitutes the terminus of the peptide part of the peptidoglycan monomer unit and is involved in the transpeptidation reaction as the substrate. D-Ala-D-Ala is catalyzed by D-Alanine-D-Alanine ligase.
    D-Ala-D-Ala
  • HY-P4253A
    Arginyl-Glutamine TFA 99.22%
    Arginyl-Glutamine TFA is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Arginyl-Glutamine TFA
  • HY-131092A
    H-Asn-Arg-OH diTFA
    H-Asn-Arg-OH (diTFA) is a dipeptide formed by the connection of asparagine and arginine via a peptide bond, which can be used in polypeptide synthesis.
    H-Asn-Arg-OH diTFA
  • HY-P4668A
    Valylleucine TFA 27530-02-5 98.63%
    Valylleucine TFA is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Valylleucine TFA
  • HY-W010276
    Gly-Sar 29816-01-1 99.56%
    Gly-Sar is a Glycine (HY-Y0966) derivative.
    Gly-Sar
  • HY-P1939
    Cyclo(L-Leu-L-Pro) 2873-36-1 99.84%
    Cyclo(L-Leu-L-Pro) is an inhibitory substance targeting to production of norsolorinic acid (NA，a precursor of aflatoxin)，which can be isolated from A. xylosoxidans NFRI-A1. Cyclo(L-Leu-L-Pro) inhibits accumulation of NA by A. parasiticus NFRI-95 and inhibits spore formation. Cyclo(L-Leu-L-Pro) inhibits aflatoxin production with an IC50 of 0.2 mg/mL in A. parasiticus SYS-4.
    Cyclo(L-Leu-L-Pro)
  • HY-W092109
    H-Phe-Trp-OH 24587-41-5 99.22%
    H-Phe-Trp-OH (Phenylalanyltryptophan) is an endogenous metabolite.
    H-Phe-Trp-OH
  • HY-W008642
    Leu-Leu-OH 3303-31-9 98.75%
    Leu-Leu-OH (L-Leucyl-L-leucine), a Leu derivative, is a neutral dipeptide that can be used to study the functionality of dileucine motifs.
    Leu-Leu-OH
  • HY-112173
    Prolylleucine 61596-47-2 99.85%
    Prolylleucine is a dipeptide containing branched-chain amino acids. Prolylleucine can affect the circadian rhythms and behaviour of animals.
    Prolylleucine
  • HY-W016887
    Glycyl-L-proline 704-15-4 99.91%
    Glycyl-L-proline (H-Gly-Pro-OH) is an end product of collagen metabolism that is further cleaved by prolidase.
    Glycyl-L-proline
  • HY-P4617
    Cyclo(-Leu-Phe) 7280-77-5 99.58%
    Cyclo(-Leu-Phe) is a cyclic peptide composed of leucine and phenylalanine, forming a ring structure through peptide bonds.
    Cyclo(-Leu-Phe)
  • HY-W013998
    Glycyl-L-phenylalanine 3321-03-7 99.74%
    Glycyl-L-phenylalanine is a phenylalanine derivative.
    Glycyl-L-phenylalanine
  • HY-W009686
    L-Prolyl-L-leucine 52899-07-7 99.87%
    L-Prolyl-L-leucine is a leucine derivative.
    L-Prolyl-L-leucine
  • HY-42709
    Z-Val-Ala-OH 24787-89-1 99.78%
    Z-Val-Ala-OH is a dipeptide derivative of valine and alanine.
    Z-Val-Ala-OH
  • HY-113003
    H-γ-Glu-Gln-OH 10148-81-9 98.04%
    H-γ-Glu-Gln-OH is a hydrophilic peptide and can be conjugated to drugs. The carrier composed of H-γ-Glu-Gln-OH has the characteristics of high water solubility and drug-loading capacity, good biocompatibility, low toxicity, improved tumor targeting ability, and anti-tumor efficacy.
    H-γ-Glu-Gln-OH
  • HY-131095
    Z-Glu-Tyr-OH 988-75-0 99.17%
    Z-Glu-Tyr-OH can be used for synthesis of peptides on a solid support.
    Z-Glu-Tyr-OH